| Date | Title | Description |
| 07.06.2024 | Most-Active US Investors In May: Andreessen Horowitz And General Catalyst Lead Month With A Lot Of Big Rounds | 9 Shares Email Facebook Twitter LinkedIn
This is a monthly feature that runs down some of the most-active investors in U.S.-based companies, looks at some of their most interesting investments, and includes some odds and ends of who spent w... |
| 03.05.2024 | Karius Revolutionizes Infectious Disease Diagnostics with $100M Funding Boost | Karius, a genomic diagnostics powerhouse, has secured a whopping $100 million in Series C funding to expand its groundbreaking Karius Test. This test, a game-changer in infectious disease diagnosis, uses cutting-edge genomic analysis and AI... |
| 03.05.2024 | Infectious disease DNA tester Karius nets $100M to expand liquid biopsy reach | The infectious disease diagnostic developer Karius has secured another $100 million to help expand the reach of its microbial DNA test designed to detect more than 1,000 different pathogens from a single blood sample.
The Fierce Medtech Fie... |
| 02.05.2024 | Karius Raises $100M in Series C Funding | Karius, Inc., a Redwood City, CA-based leader in genomic diagnostics for infectious disease, raised $100m in Series C funding.
The round was co-led by Khosla Ventures and new investors 5AM Ventures and Gilde Healthcare. Also investing was n... |
| 02.05.2024 | Karius Secures $100M to Expand Non-Invasive Pathogen Blood Test | What You Should Know:
– Karius®, a leader in genomic diagnostics for infectious disease, announced today the closing of a $100 million Series C funding round.
– Co-led by Khosla Ventures and newcomers 5AM Ventures and Gilde Healthcare, the ... |
| 27.06.2022 | LakeFS brings branching to data lakes | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Can enterprises find a better way to organize the... |
| 17.12.2021 | Risk, M&A and IPOs—here’s what mattered to CFOs this week | This is the web version of CFO Daily, a newsletter on the trends and individuals shaping corporate finance. Sign up to get it delivered free to your inbox.
Good morning,
Every Friday, I sum up the week. But before I do that, I’d like to sum... |
| 14.12.2021 | This was a big year for IPOs, but the struggle is real in a ‘perfect storm’ | This is the web version of CFO Daily, a newsletter on the trends and individuals shaping corporate finance. Sign up to get it delivered free to your inbox.
Good morning,
2021 has been a record-breaking year for IPOs in the U.S.
This year, I... |
| 27.10.2021 | Karius Test Named “Infectious Disease Testing Solution of the Year” at Inaugural 2021 BioTech Breakthrough Awards | For the most vulnerable patients, getting the right diagnosis in a timely manner can sometimes be the difference between life and death - Alec Ford, CEO of Karius
LOS ANGELES (PRWEB) October 27, 2021
Karius, the world leader in liquid biops... |
| 17.08.2021 | Karius receives New York State permit for its liquid biopsy test to detect infectious diseases | REDWOOD CITY, Calif., Aug. 17, 2021 /PRNewswire/ -- Karius, the world leader in liquid biopsy for infectious diseases, has received approval from the New York State Department of Health's Clinical Laboratory Evaluation Program (CLEP) for it... |
| 17.08.2021 | Karius receives New York State permit for its liquid biopsy test to detect infectious diseases | |
| 02.09.2020 | SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis | Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Sin... |
| 28.02.2020 | Karius: This Liquid Biopsy Company Just Raised $165 Million Led By SoftBank | Liquid biopsy leader Karius announced it raised $165 million in a new round of funding led by SoftBank Vision Fund 2
Karius — a leader in liquid biopsy for infectious diseases — announced it has raised $165 million in a new round of funding... |
| 24.02.2020 | Karius raises $165 million to identify infectious diseases with AI | Approximately 9% of the U.S. population has been diagnosed with an infectious disease. Worldwide, these diseases are the second-leading cause of death after heart disease, and they’re responsible for more deaths annually than cancer.
Mickey... |
| 24.02.2020 | Karius, using liquid biopsy to detect infectious diseases, raises $165M in Series B round | The company plans to use the funding to expand its reach and also support future clinical studies. Karius is used in more than 100 hospitals and health systems around the country. It is designed to detect more than 1,000 bacteria, viruses, ... |
| 24.02.2020 | Karius raises $165 million for its liquid biopsy technology identifying diseases with a blood draw | “What Karius is good at is identifying those novel microbes before they become an outbreak like coronavirus,” says Mickey Kertesz, a chief executive whose life sciences startup just hauled in $165 million in new funding.
While the new money... |
| 24.02.2020 | Karius raises $165 million to identify infectious diseases with AI | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Approximately 9% of the U.S. population has been diagnosed with an infectious disease. Worldwide, these diseases are the second-leading... |
| 24.02.2020 | Karius secures $165M In Series B funding led by SoftBank to provide genomic insights for infectious diseases | Karius, a life sciences startup that markets a test that can quickly detect hard-to-diagnose infections through a simple taking of blood, has secured $165 million in a new funding round led by SoftBank Vision Fund 21, with additional partic... |
| 24.02.2020 | Karius nets $165M from SoftBank and more to power its infection genomics test | Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s upcoming sequel to its technology-focused venture capital megafund.
Sponsored by Agilent Technologies
How would you ... |
| 24.02.2020 | Karius Secures $165M in Series B |
REDWOOD CITY, CA, Karius secured $165 million in a new funding round led by SoftBank Vision Fund 2.
>> Click here for more funding data on Karius
>> To export Karius funding data to PDF and Excel, click here
Karius, the w... |
| 24.02.2020 | Top tech startup news for today, Monday, February 24, 2020: Facebook, Microsoft, Apple, Softbank, Behavox, Intuit | Good morning! Below are the top tech startups news for today, Monday, February 24, 2020.
Former Facebook’s sustainability chief launches ClimateVoice to help employees push companies on climate. With hundreds of companies have committed to... |
| 24.02.2020 | Karius Raises $165M In Series B Funding | Karius, a Redwood City, Calif.-based developer of liquid biopsy solutions for infectious diseases, secured $165m in funding.
The round was led by SoftBank Vision Fund 21, with additional participation from General Catalyst, HBM Healthcare I... |
| 24.02.2020 | SoftBank leads US$165 million capital boost for liquid biopsy firm Karius | REUTERS: SoftBank's second Vision Fund has led a new US$165 million funding round in California-based Karius, which markets a test that can quickly detect hard to diagnose infections through a simple taking of blood, the start-up said on Mo... |
| 24.02.2020 | Karius raises $165 million for its liquid biopsy technology identifying diseases with a blood draw | - |
| 24.02.2020 | Karius nets $165M from SoftBank and more to power its infection genomics test | Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s upcoming sequel to its technology-focused venture capital megafund.
Karius’ microbial DNA test is already in use at ... |
| 02.08.2019 | Reinventing the doctor - week 3 | Keith Rabois (Founders Fund), Dr. Michael Abramoff (IDx), Dr. Arif Nathoo (Komodo Health) and more
Welcome to "Reinventing the doctor" - week 3, my weekly curation of news and information around the Internet that's relevant to our... |
| 30.11.2018 | Karius Receives $25M Senior Secured Facility | Karius, a Redwood City, CA-based life science company focused on infectious disease diagnostics with genomics, received a $25 million senior secured facility.
Oxford Finance provided the financing.
The company will use the funds to expand t... |
| 29.11.2018 | Karius Secures $25M Financing From Oxford Finance | Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $25 million senior secured term loan with Karius, Inc., a life science company trans... |
| 01.10.2018 | SplashX: how does precision health change the doctor’s role? | Investors and entrepreneurs in precision health weighed in on how data is changing the relationship
Last week, Vator held a salon, SplashX Invent Health - Precision Health, co-hosted and co-produced by our awesome partner, HP, where we took... |
| 01.03.2018 | Meet Scott Barclay, Investing Partner at Data Collective | An investor in sci-fi-like digital health looks to revolutionize 'failed' healthcare system
As entrepreneurship has become a global meme, with the title of "Founder" worn like a badge of accomplishment, there's no shortage of emer... |
| 07.08.2017 | Karius Secures $50M in Series A Funding | Karius, Inc., a Redwood City, Calif.–based life sciences company focused on treating infectious diseases, secured $50m in Series A funding.
The round was led by Data Collective and Lightspeed Venture Partners with participation from Tencent... |
| 07.08.2017 | Karius Announces $50M in Series A |
REDWOOD CITY, CA, Life sciences company focused on conquering infectious diseases, today announced that the company has raised $50 million in Series A.
>> Click here for more funding data on Karius
>> To export Karius fundin... |
| 07.08.2017 | Term Sheet — Monday, Aug. 7 | STUPID AMOUNTS OF MONEY
Good morning! Three quick things:
Paid Content How can you protect what you can't see? From ExtraHop
To wildly understate things, a SoftBank deal would be complicated. SoftBank is already invested in pretty much all ... |
| - | Karius | “The Karius Test™ is a liquid biopsy that can non-invasively and rapidly detect over 1000 pathogens causing both deep-seated and bloodstream infections from a single blood sample.” |
| - | Healthcare startups netted a record number of mega-deals last quarter. Meet the 10 companies pulling in the most cash. | A KRY physician examines a patient. KRY This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Investors poured $14.6 billion into healthcare startups during the first quarter of 2020.
Digital h... |
| - | Karius, using liquid biopsy to detect infectious diseases, raises $165M in Series B round | A company developing liquid biopsy technology for use in diagnosing infectious diseases has netted a big investment from SoftBank and others.
Redwood City, California-based Karius said Monday that it had raised $165 million in a Series B fu... |
| - | Karius: Genomic Diagnostics Company Secures $100 Million | Karius, a leader in genomic diagnostics for infectious disease, announced it has secured $100 million in Series C funding. The funding round was co-led by Khosla Ventures and new investors 5AM Ventures and Gilde Healthcare. Also joining thi... |
| - | The diagnostic dilemma of co-infections requires novel solutions | Vector flat blood laboratory icon illustration. Magnifier glass zoom blood drop cell. Concept of DNA, HIV diagnosis lab. Design element for poster, flyer, card, banner, ui
Covid-19 patients with co-infections suffer longer hospital stays an... |
